Motus Biosciences Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Motus Biosciences General Information

Description

Developer of tools intended for the development of next-generation gene therapies. The company specializes in Ramping IND applications for GT's and AVV based gene therapy.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 3210 Merryfield Row
  • Suite 2304A
  • San Diego, CA 92121
  • United States
Primary Industry
Biotechnology
Acquirer
Corporate Office
  • 3210 Merryfield Row
  • Suite 2304A
  • San Diego, CA 92121
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Motus Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Motus Biosciences‘s full profile, request access.

Request a free trial

Motus Biosciences Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Motus Biosciences‘s full profile, request access.

Request a free trial

Motus Biosciences FAQs

  • When was Motus Biosciences founded?

    Motus Biosciences was founded in 2020.

  • Where is Motus Biosciences headquartered?

    Motus Biosciences is headquartered in San Diego, CA.

  • What industry is Motus Biosciences in?

    Motus Biosciences’s primary industry is Biotechnology.

  • Is Motus Biosciences a private or public company?

    Motus Biosciences is a Private company.

  • What is the current valuation of Motus Biosciences?

    The current valuation of Motus Biosciences is .

  • What is Motus Biosciences’s current revenue?

    The current revenue for Motus Biosciences is .

  • Who are Motus Biosciences’s investors?

    Green Sands Equity has invested in Motus Biosciences.

  • When was Motus Biosciences acquired?

    Motus Biosciences was acquired on 04-Aug-2021.

  • Who acquired Motus Biosciences?

    Motus Biosciences was acquired by Insmed.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »